Duchenne's progressive muscular dystrophy (Duchenne's PMD) is a severe genetic disorder.
Anesthesia poses significant risks for patients with Duchenne's PMD.
Observation:
Recent case reports highlight anesthesia-related hazards during induction and postoperative recovery.
Patients with Duchenne's PMD may exhibit hyperpyrexia-like responses, including cardiac arrest, elevated creatine phosphokinase, myoglobinuria, and metabolic acidosis after suxamethonium or halothane.
In vitro muscle tests suggest a potential for malignant hyperpyrexia during general anesthesia.
Findings:
Six children with Duchenne's PMD experienced delayed respiratory insufficiency post-anesthesia, necessitating mechanical ventilation.
Five of these children suffered cardiac arrest despite adequate respiratory support.
Suxamethonium was a common factor in the anesthesia received by all six patients.
Implications:
These findings underscore the critical need for careful anesthetic management in Duchenne's PMD patients.
Avoiding suxamethonium may mitigate risks, as evidenced by one patient's uneventful subsequent anesthetics without it.
Further research into anesthetic protocols for Duchenne's PMD is warranted to improve patient safety and outcomes.